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Summarv and conclusions
Aim of the study
Patients with chronic nonspecific lung disease (CNSLD) are characterized
by increased airway reactivity to both specific (allergic) and non-specific
environmental triggers, leading to dyspnea and/or cough.
Immunological processess play an important role in the reactions to
specific factors. Especially the role of elevated levels of allergen specific IgE
class antibody has been studied extensively in the past. The first question is
whether increased levels of antibody result from increased exposure to the
allergen in question to the immunocompetent cells, possibly due to increased
permeabil ity of the bronchial membrane, or from different immune
regulation. The next question is whether a possible difference in immune
regulation only applies to the IgE class antibody response, or has also
consequences for antibody responses in other immunoglobulin classes and
for the cell-mediated immune response.
The latter aspect is of particular interest as cell-mediated immune
reactions are very sensitive to corticosteroid hormones. This is clearly
il lustrated by the inverse correlation between endogenously produced
corticosteroid hormones and the number of immunocompetent cells in
animal experiments (Del Rey, 1984). These hormones are known to show
beneficial effects in patients with CNSLD, even in relatively low doses. The
therapeutic success of corticosteroid medication was found to correlate with
the sensitivity of the lymphocytes of the same patients to the dampening
influence of the steroid hormone on in vitro proliferative responses
(Poznansky, 1985). In vitro lymphocyte proliferation to allergens was found
to be increased in patients with CNSLD (Rawle, 1984). Furthermore the
number of mononuclear cells in (Godard, 1981) and round (Dunnil l, 1984)
the bronchi appeared to be increased in CNSLD. The relevance of cell-
mediated immune reactions for the pathogenesis of CNSLD is increasingly
recognized, as lymphocyte derived factors may play a role in inducing
proliferation (Razin, 1984), attraction (Mitchell, 1984) and degranulation
(Sedgwick, 1981) of mediator cells.
This study was designed to measure the humoral and cell-mediated
immune response in patients with CNSLD after a carefully standardized
immunological trigger. The function of the adrenal cortex was measured
under basal and ambulant conditions. Furthermore the relation between the
function of the adrenal cortex and the amplitude of the immune response was
evaluated in patients with CNSLD and controls.
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Summary of the results
Young.  malc,  a l lerg ic  pat icnts wi th CNSLD, showing thc c l in ica l  p ic turc
of  bronchia l  asthma, were testcd dur ing a symptom f ree pcr iod.  These
pat ients werc compared wi th an age matched contro l  group.  The inrmune
response was measured af ter  subcutaneous immunizat ion wi th the pr imary
immunogen Hel ix  pomat ia Haentocyanin (HPH).  th t rs  of fer ing a d i rect ,
s tandarc i izcd t r iggcr  to the immune system.
The ant ibody rcsponses to HPH in the IgE and IgG c lasses appeared to be
highest  in  the pat ient  group (c l rapter  I  ) .  IgA c lass ant ibody responses in the
pat ients tended to be h igher  as wel l ,  though th is  was not  s tat is t ica l ly
s igni f icant .  IgM c lass ant ibody rcsponses were nornta l  in  the pat ient  group,
apart  f rom tcmporar i ly  c levated values in  the ear ly  phase of  the response.
Thus ant ibody responses af ter  s tandardized immunizat ion tended to be
elevatcc i  n the pat icnts,  suggest ing a d is turbance in immune regulat ion
which is  cxprcssed increasingly  in  the order  IgM-IgA-IgG/ lgE.
Ant ibody responses in the IgG, IgE and IgA c lasses appeared to be
corre lated.  IgM c lass ant ibody responses,  however,  were not  corre lated wi th
the rcsponses in the othcr  ant ibodv c lasses.
Elevated primary IgE class antibody responses to HPH were alsc.r observed
in pat ients wi th CNSLD, who are sk in test  r - regat ive to a l lergens (d isc I .B) .
Ant i -HPH IgE c lass ant ibody lcvels  appeared to be corre lated wi th the
diameters of  HPH-inc luced sk in react ions at  15 minutes and 8 hours.  br- r t  not
wi th thc react ion at21 and 48 hours af ter  sk in test ing (d isc I I .C) .
HPH-induced sk in react ions at  r . l  and 48 hours.  and HPH-induced in v i t ro
lymphocvte pro l i fcrat ion responses were compared bctween pat ients and
controls in chapter 2. No diffcrences could be obscrved between the two
groups wi th respect  to  these parameters for  the cel l -mediated i rnmune
response. In vitro lymphocyte proliferation appeared to be correlated with
the sk in test  d iameter  at  24 hours.  In  v i t ro and in v ivo cel l  mediated responses
were corre lated only wi th IgM c lass ant ibody responses,  but  not  wi th the
responses in IgG, IgE, or IgA antibody classes.
The HPH-specific IgE antibody response in patients and controls was
compared wi th the IgE c lass ant ibody levels to the a l lergen housedustmi te
and a major  a l lergen f rom th is  ext ract  (P 1) .  This  compar ison revealed a rnuch
larger  d i f ference in ant i  P l  ant ibody levels between pat ients and contro ls ,
duc to the i rbscnce of  ant i -P 1 ant ibody in  the contro l  group.  This observat ion
could not  be expla ined by the d i f ferences in  i rnmunoregulat ion,  as refected in
the HPH response,  a lone (d isc I .C) .  Fur thermore other  s tudies revealed that
in  v i t ro cel l -mediated responses to ant igen P1 could be induced in pat ients
wi th CNSLD. but  wcre low or  absent  in  contro ls .  Therefore i t  was
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